SURFACE ONCOLOGY INC's ticker is SURF and the CUSIP is 86877M209. A total of 91 filers reported holding SURFACE ONCOLOGY INC in Q4 2020. The put-call ratio across all filers is 1.70 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2023 | $5,852 | – | 6,726 | +7291.2% | 0.00% | – |
Q1 2023 | $0 | -100.0% | 91 | -97.9% | 0.00% | – |
Q4 2022 | $3 | -100.0% | 4,291 | -88.5% | 0.00% | -100.0% |
Q3 2022 | $39,000 | +387.5% | 37,300 | +646.9% | 0.00% | – |
Q2 2022 | $8,000 | -88.9% | 4,994 | -79.9% | 0.00% | -100.0% |
Q1 2022 | $72,000 | +620.0% | 24,791 | +1111.7% | 0.00% | – |
Q4 2021 | $10,000 | +11.1% | 2,046 | +80.7% | 0.00% | – |
Q3 2021 | $9,000 | -84.2% | 1,132 | -85.2% | 0.00% | -100.0% |
Q2 2021 | $57,000 | -16.2% | 7,624 | -12.2% | 0.00% | 0.0% |
Q1 2021 | $68,000 | -31.3% | 8,683 | -18.8% | 0.00% | -66.7% |
Q4 2020 | $99,000 | +9800.0% | 10,687 | +5243.5% | 0.00% | – |
Q3 2020 | $1,000 | -95.0% | 200 | -98.1% | 0.00% | -100.0% |
Q1 2020 | $20,000 | +81.8% | 10,712 | +83.4% | 0.00% | 0.0% |
Q4 2019 | $11,000 | -69.4% | 5,841 | -77.1% | 0.00% | -50.0% |
Q3 2019 | $36,000 | +111.8% | 25,497 | +323.9% | 0.00% | +100.0% |
Q2 2019 | $17,000 | -74.6% | 6,015 | -57.1% | 0.00% | -75.0% |
Q1 2019 | $67,000 | +509.1% | 14,036 | +428.5% | 0.00% | +300.0% |
Q4 2018 | $11,000 | -45.0% | 2,656 | +46.7% | 0.00% | 0.0% |
Q3 2018 | $20,000 | – | 1,811 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Atlas Venture Associates IX, LLC | 2,945,453 | $22,297,000 | 7.41% |
ACT CAPITAL MANAGEMENT, LLC | 170,500 | $1,291,000 | 0.67% |
SummerHaven Investment Management, LLC | 128,078 | $970,000 | 0.57% |
Parkman Healthcare Partners LLC | 248,267 | $1,879,000 | 0.48% |
SILVERARC CAPITAL MANAGEMENT, LLC | 50,000 | $379,000 | 0.21% |
C M BIDWELL & ASSOCIATES LTD | 33,030 | $250,000 | 0.17% |
ARK Investment Management | 4,618,354 | $34,961,000 | 0.08% |
Knights of Columbus Asset Advisors LLC | 114,594 | $867,000 | 0.08% |
Orbimed Advisors | 909,666 | $6,886,000 | 0.08% |
HighVista Strategies LLC | 13,932 | $105,000 | 0.07% |